For years we’ve known that drug-resistant infections – also known as antimicrobial resistance (AMR) – are a big threat to human health. By 2050, as many people could die from them as cancer; with the highest rates among over-70s and young children (read article).
What is (or isn’t) being done
To help tackle the issue of AMR, there have been national task forces, international movements and countless research papers from across disciplines. I’ve also recently returned from the United Nations General Assembly (UNGA) for the High-Level Meeting (HLM) on AMR, where 193 world leaders committed to taking action and reducing deaths, with each one asserting that they’re taking this issue seriously.